#BEGIN_DRUGCARD DB04647

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C26H41BN4O10

# Chemical_IUPAC_Name:
(2S)-4-{[(1S)-5-{[(benzyloxy)carbonyl]amino}-1-{[(1S)-1-(dihydroxyboranyl)ethyl]carbamoyl}pentyl]carbamoyl}-2-{[(tert-butoxy)carbonyl]amino}butanoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2007-09-11 11:49:09 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
BOC-GAMMA-D-GLU-L-LYS(CBZ)-D-BOROALA

# HET_ID:
BO9

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C26H41BN4O10/c1-17(27(38)39)29-22(33)19(12-8-9-15-28-24(36)40-16-18-10-6-5-7-11-18)30-21(32)14-13-20(23(34)35)31-25(37)41-26(2,3)4/h5-7,10-11,17,19-20,38-39H,8-9,12-16H2,1-4H3,(H,28,36)(H,29,33)(H,30,32)(H,31,37)(H,34,35)/t17-,19+,20+/m1/s1

# InChI_Key:
InChIKey=OTTYWVUOPWENAJ-HOJAQTOUSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4647

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
580.436

# Molecular_Weight_Mono:
580.291574018

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
Not Available

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
1.17

# Predicted_LogS:
-4.4

# Predicted_Water_Solubility:
2.37e-02 g/l

# Primary_Accession_No:
DB04647

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
5287824

# PubChem_Substance_ID:
46508422

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
Not Available

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
C[C@@H](NC(=O)[C@H](CCCCNC(=O)OCC1=CC=CC=C1)NC(=O)CC[C@H](NC(=O)OC(C)(C)C)C(O)=O)B(O)O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:33 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cell inner membrane (By similarity)

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
15938610	Nicola G, Peddi S, Stefanova M, Nicholas RA, Gutheil WG, Davies C: Crystal structure of Escherichia coli penicillin-binding protein 5 bound to a tripeptide boronic acid inhibitor: a role for Ser-110 in deacylation. Biochemistry. 2005 Jun 14;44(23):8207-17.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AE014075

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
dacA

# Drug_Target_1_Gene_Sequence:
>1212 bp
TTAACCAAACCAGTGATGGAACATTAATTTAATGTAATCAATGATTTTGCCGAAGAAGTT
ACCTTCCGGTATTTCTTGCAGCACAACCAGCGGGCGTTGTTCGATCGTTTTGCCATCAAG
CTGGAAGTTGATAGTTCCGACGACCTGATTCTTTTGCAGCGGCGCATGCAATTCACTGCT
GTTCAGCACATAGCTGGCTTTCAGATCTTTCATGCGACCACGCGGAATGGTCAGGTACAC
GTCTTTATCAACCCCTAACGAAGCGCGATCAGAATCACCAAACCAAACCGGTTCAGAGGC
GAACTCTTTACCTACTTTCAGTGGGTTAACGGTTTCGAAGAAACGGAAGCCCCAGGTTAG
CAATTTTTTACTTTCGGCTTCACGGCCTTTAAAAGTACGTCCGCCCATCACCGCAGAGAT
CAAGCGCATCTGGCCTTCAGTCGCAGAAGCAACAAGGTTGTACCCTGCTTTGTCAGTGTG
TCCGGTTTTGATGCCGTCGACATTCAGGCTGTTATCCCATAACAGGCCGTTACGGTTCAG
CTGGCGAATACCGTTAAACGTAAATTCTTTTTCTTTATAGATCGAGTATTCATTCGGTAC
GTCACGGATCAACGCCTGGCCGATCAGCGCCATATCTCGCGCGGAGCTGTACTGACCATC
AGCATCCAGACCGTGTACCGTCTGGAAGTGGGTATTTTTCAGGCCCAGGGCGTTAACGTA
GCTGTTCATCAAGCCAACAAAAGCGTCCTGGCTACCAGCGGCAAAATCGGCCATGGCGAC
ACAAGCATCGTTACCCGATTGCAGGTTAATACCGCGGATCAGCTGAGAAACCGGAACCTG
CATGCCCGGTTTGAGGAACATCAGCGAAGAACCTTTAAACACCGGGTTACCGGTGGCCCA
TGCGTCGTTGCCGATAGTGACTAAATCAGTTTCTTTAAATTTACCGGCTTTCATTGCCTG
GCCGATAACGTAACTGGTCATCATTTTGGTCAGGCTGGCAGGATCGCGGCGGACATCAGC
GTTCTGTTCGGCGAGTACTTTGCCGGAGTTGTAGTCAATCAGGATGTAGGACTCCGCGTC
GATCTGCGGTACACCCGGGATCATGGTTTTGATATTCAGGTCATCGGCATGTGCAGCAGA
GATAAAGGCTGTGCAAAGAGCCGTGGTGAGCGCCAGGCGCTTCATGATACGAGCGGAAAA
AATGGTATTCAT

# Drug_Target_1_General_Function:
Involved in serine-type D-Ala-D-Ala carboxypeptidase activity

# Drug_Target_1_General_References:
12471157	Welch RA, Burland V, Plunkett G 3rd, Redford P, Roesch P, Rasko D, Buckles EL, Liou SR, Boutin A, Hackett J, Stroud D, Mayhew GF, Rose DJ, Zhou S, Schwartz DC, Perna NT, Mobley HL, Donnenberg MS, Blattner FR: Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):17020-4. Epub 2002 Dec 5.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
4252

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
44445

# Drug_Target_1_Name:
Penicillin-binding protein 5

# Drug_Target_1_Number_of_Residues:
403

# Drug_Target_1_PDB_ID:
1NZU

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00768	Peptidase_S11
PF07943	PBP5_C

# Drug_Target_1_Protein_Sequence:
>Penicillin-binding protein 5
MNTIFSARIMKRLALTTALCTAFISAAHADDLNIKTMIPGVPQIDAESYILIDYNSGKVL
AEQNADVRRDPASLTKMMTSYVIGQAMKAGKFKETDLVTIGNDAWATGNPVFKGSSLMFL
KPGMQVPVSQLIRGINLQSGNDACVAMADFAAGSQDAFVGLMNSYVNALGLKNTHFQTVH
GLDADGQYSSARDMALIGQALIRDVPNEYSIYKEKEFTFNGIRQLNRNGLLWDNSLNVDG
IKTGHTDKAGYNLVASATEGQMRLISAVMGGRTFKGREAESKKLLTWGFRFFETVNPLKV
GKEFASEPVWFGDSDRASLGVDKDVYLTIPRGRMKDLKASYVLNSSELHAPLQKNQVVGT
INFQLDGKTIEQRPLVVLQEIPEGNFFGKIIDYIKLMFHHWFG

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
1-29

# Drug_Target_1_Specific_Function:
Removes C-terminal D-alanyl residues from sugar-peptide cell wall precursors (By similarity)

# Drug_Target_1_SwissProt_ID:
P0AEB3

# Drug_Target_1_SwissProt_Name:
DACA_ECOL6

# Drug_Target_1_Synonyms:
D-alanyl-D-alanine carboxypeptidase fraction A
DD- carboxypeptidase
DD-peptidase
EC 3.4.16.4
PBP-5
Penicillin-binding protein 5 precursor

# Drug_Target_1_Theoretical_pI:
8.58

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cell inner membrane. Note=N-terminal lies in the periplasmic space

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
Not Available

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
X06479

# Drug_Target_2_GenBank_ID_Protein:
Not Available

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
dacA

# Drug_Target_2_Gene_Sequence:
Not Available

# Drug_Target_2_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_2_General_References:
1597468	Malhotra KT, Nicholas RA: Substitution of lysine 213 with arginine in penicillin-binding protein 5 of Escherichia coli abolishes D-alanine carboxypeptidase activity without affecting penicillin binding. J Biol Chem. 1992 Jun 5;267(16):11386-91.
3279397	Broome-Smith JK, Ioannidis I, Edelman A, Spratt BG: Nucleotide sequences of the penicillin-binding protein 5 and 6 genes of Escherichia coli. Nucleic Acids Res. 1988 Feb 25;16(4):1617.
3316191	Takase I, Ishino F, Wachi M, Kamata H, Doi M, Asoh S, Matsuzawa H, Ohta T, Matsuhashi M: Genes encoding two lipoproteins in the leuS-dacA region of the Escherichia coli chromosome. J Bacteriol. 1987 Dec;169(12):5692-9.
6319180	Broome-Smith J, Spratt BG: An amino acid substitution that blocks the deacylation step in the enzyme mechanism of penicillin-binding protein 5 of Escherichia coli. FEBS Lett. 1984 Jan 9;165(2):185-9.
7042389	Waxman DJ, Amanuma H, Strominger JL: Amino acid sequence homologies between Escherichia coli penicillin-binding protein 5 and class A beta-lactamases. FEBS Lett. 1982 Mar 22;139(2):159-63.
8424800	van der Linden MP, de Haan L, Keck W: Domain organization of penicillin-binding protein 5 from Escherichia coli analysed by C-terminal truncation. Biochem J. 1993 Jan 15;289 ( Pt 2):593-8.
8905232	Oshima T, Aiba H, Baba T, Fujita K, Hayashi K, Honjo A, Ikemoto K, Inada T, Itoh T, Kajihara M, Kanai K, Kashimoto K, Kimura S, Kitagawa M, Makino K, Masuda S, Miki T, Mizobuchi K, Mori H, Motomura K, Nakamura Y, Nashimoto H, Nishio Y, Saito N, Horiuchi T, et al.: A 718-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 12.7-28.0 min region on the linkage map. DNA Res. 1996 Jun 30;3(3):137-55.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
3760

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
44445

# Drug_Target_2_Name:
Penicillin-binding protein 5 precursor

# Drug_Target_2_Number_of_Residues:
403

# Drug_Target_2_PDB_ID:
1NZU

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00768	Peptidase_S11
PF07943	PBP5_C

# Drug_Target_2_Protein_Sequence:
>Penicillin-binding protein 5 precursor
MNTIFSARIMKRLALTTALCTAFISAAHADDLNIKTMIPGVPQIDAESYILIDYNSGKVL
AEQNADVRRDPASLTKMMTSYVIGQAMKAGKFKETDLVTIGNDAWATGNPVFKGSSLMFL
KPGMQVPVSQLIRGINLQSGNDACVAMADFAAGSQDAFVGLMNSYVNALGLKNTHFQTVH
GLDADGQYSSARDMALIGQALIRDVPNEYSIYKEKEFTFNGIRQLNRNGLLWDNSLNVDG
IKTGHTDKAGYNLVASATEGQMRLISAVMGGRTFKGREAESKKLLTWGFRFFETVNPLKV
GKEFASEPVWFGDSDRASLGVDKDVYLTIPRGRMKDLKASYVLNSSELHAPLQKNQVVGT
INFQLDGKTIEQRPLVVLQEIPEGNFFGKIIDYIKLMFHHWFG

# Drug_Target_2_Reaction:
Preferential cleavage: (Ac)2-L-Lys-D-Ala-|-D-Ala. Also transpeptidation of peptidyl-alanyl moieties that are N-acyl substituents of D-alanine

# Drug_Target_2_Signals:
1-29

# Drug_Target_2_Specific_Function:
Removes C-terminal D-alanyl residues from sugar-peptide cell wall precursors

# Drug_Target_2_SwissProt_ID:
P0AEB2

# Drug_Target_2_SwissProt_Name:
DACA_ECOLI

# Drug_Target_2_Synonyms:
D-alanyl-D-alanine carboxypeptidase fraction A
DD- carboxypeptidase
DD-peptidase
EC 3.4.16.4
PBP-5

# Drug_Target_2_Theoretical_pI:
8.58

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB04647
